SC 13G Filing

Company

Aurinia Pharmaceuticals Inc.

Filed

February 16, 2016

Accession Number

0001425738-16-000030

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →